MedTrace Logo

Lorcaserin for Weight Loss Management in Patients on Antipsychotics: A Pilot Study

NCT01962402 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2014-01-30

No results posted yet for this study

Summary

The purpose of this study is to determine whether lorcaserin is effective for weight reduction in patients with weight gain as a result of antipsychotic medications.

Conditions

  • Weight Gain

Interventions

DRUG

lorcaserin

Patients will receive lorcaserin 10mg tablet, 1 tablet twice daily for 12 weeks.

BEHAVIORAL

Intensive dietary counseling

All patients in the study will receive intensive dietary counseling, encouraging eating minimal carbohydrates and sugars.

Sponsors & Collaborators

  • Southern California Institute for Research and Education

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01962402 on ClinicalTrials.gov